Adult Low Dose Aspirin

Product NDC: 16103-356
11-digit product format: 161030356
Labeler code: 16103
Product ID: 16103-356_9c7048f1-9ac5-431b-9279-ee6ce88e6d71
Type: HUMAN OTC DRUG
Nonproprietary name: Aspirin
Dosage form: TABLET, DELAYED RELEASE
Route: ORAL
Labeler: Pharbest Pharmaceuticals, Inc.
Application: M
Marketing category: OTC MONOGRAPH DRUG
Marketing start: 2007-01-12
Substance: ASPIRIN
Active strength: 81 mg/1
Pharmacologic classes: Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC]
NDC exclude flag: No
Listing certified through: 2027-12-31
Current FDA listing: Yes

Observed NDC auxiliary status history#

This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.

Historic NDC status page 1 of 1 · 36 matching rows.

View current auxiliary records. · View the auxiliary file history.

Captured / source date, Dataset, Scope table
Captured / source date	Dataset	Scope	Package NDC	Code	Status	Snapshot	Source SHA-256
2025-12-14 17:58 UTC · source 2025-12-05	excluded product	product		I	Inactivated by FDA	`d630ba8d3edf…`	`732f749b63fb…`
2025-12-14 17:58 UTC · source 2025-12-05	excluded package	package	16103-356-09	I	Inactivated by FDA	`d630ba8d3edf…`	`732f749b63fb…`
2025-12-14 17:58 UTC · source 2025-12-05	excluded package	package	16103-356-11	I	Inactivated by FDA	`d630ba8d3edf…`	`732f749b63fb…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded product	product		I	Inactivated by FDA	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded package	package	16103-356-09	I	Inactivated by FDA	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded package	package	16103-356-11	I	Inactivated by FDA	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded product	product		I	Inactivated by FDA	`2ef7874e63bc…`	`57b86245f4fa…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded package	package	16103-356-09	I	Inactivated by FDA	`2ef7874e63bc…`	`57b86245f4fa…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded package	package	16103-356-11	I	Inactivated by FDA	`2ef7874e63bc…`	`57b86245f4fa…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded product	product		I	Inactivated by FDA	`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded package	package	16103-356-09	I	Inactivated by FDA	`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded package	package	16103-356-11	I	Inactivated by FDA	`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded product	product		I	Inactivated by FDA	`cfe11265f3b6…`	`090c488252e2…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded package	package	16103-356-09	I	Inactivated by FDA	`cfe11265f3b6…`	`090c488252e2…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded package	package	16103-356-11	I	Inactivated by FDA	`cfe11265f3b6…`	`090c488252e2…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded product	product		I	Inactivated by FDA	`cdf11ea48f46…`	`ba0047e9e063…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded package	package	16103-356-09	I	Inactivated by FDA	`cdf11ea48f46…`	`ba0047e9e063…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded package	package	16103-356-11	I	Inactivated by FDA	`cdf11ea48f46…`	`ba0047e9e063…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded product	product		U	Excluded because listing certification expired	`302b2466d912…`	`e7b80fea0513…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded package	package	16103-356-09	U	Excluded because listing certification expired	`302b2466d912…`	`e7b80fea0513…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded package	package	16103-356-11	U	Excluded because listing certification expired	`302b2466d912…`	`e7b80fea0513…`
2025-01-20 13:05 UTC · source 2025-01-20	excluded product	product		U	Excluded because listing certification expired	`ed331223b511…`	`672a5bd82f5f…`
2025-01-20 13:05 UTC · source 2025-01-20	excluded package	package	16103-356-09	U	Excluded because listing certification expired	`ed331223b511…`	`672a5bd82f5f…`
2025-01-20 13:05 UTC · source 2025-01-20	excluded package	package	16103-356-11	U	Excluded because listing certification expired	`ed331223b511…`	`672a5bd82f5f…`
2025-01-11 03:41 UTC · source 2025-01-10	excluded product	product		U	Excluded because listing certification expired	`0efc9e666f02…`	`f202fb6c5f17…`
2025-01-11 03:41 UTC · source 2025-01-10	excluded package	package	16103-356-09	U	Excluded because listing certification expired	`0efc9e666f02…`	`f202fb6c5f17…`
2025-01-11 03:41 UTC · source 2025-01-10	excluded package	package	16103-356-11	U	Excluded because listing certification expired	`0efc9e666f02…`	`f202fb6c5f17…`
2020-12-18 03:04 UTC · source 2020-12-17	excluded product	product		I	Inactivated by FDA	`e2bbac7714bc…`	`27bdfed8d636…`
2020-12-18 03:04 UTC · source 2020-12-17	excluded package	package	16103-356-09	I	Inactivated by FDA	`e2bbac7714bc…`	`27bdfed8d636…`
2020-12-18 03:04 UTC · source 2020-12-17	excluded package	package	16103-356-11	I	Inactivated by FDA	`e2bbac7714bc…`	`27bdfed8d636…`
2020-06-10 20:45 UTC · source 2020-06-10	excluded product	product		I	Inactivated by FDA	`9bebd1f3094a…`	`5416666fcb17…`
2020-06-10 20:45 UTC · source 2020-06-10	excluded package	package	16103-356-09	I	Inactivated by FDA	`9bebd1f3094a…`	`5416666fcb17…`
2020-06-10 20:45 UTC · source 2020-06-10	excluded package	package	16103-356-11	I	Inactivated by FDA	`9bebd1f3094a…`	`5416666fcb17…`
2019-12-08 06:16 UTC · source 2019-12-05	excluded product	product		E	Excluded after deficient or non-compliant submission was not corrected	`110d247fa046…`	`a55b01930146…`
2019-12-08 06:16 UTC · source 2019-12-05	excluded package	package	16103-356-11	E	Excluded after deficient or non-compliant submission was not corrected	`110d247fa046…`	`a55b01930146…`
2019-12-08 06:16 UTC · source 2019-12-05	excluded package	package	16103-356-09	E	Excluded after deficient or non-compliant submission was not corrected	`110d247fa046…`	`a55b01930146…`

Additional Listing Data#

Finished product: Yes
Brand name base: Adult Low Dose Aspirin
Listing expiration: 2027-12-31

Active Ingredients#

Ingredient, Strength table
Ingredient	Strength
ASPIRIN	81 mg/1

Harmonized UNII identifiers#

UNII identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
Identifier	FDA.report destination
R16CO5Y76E	Internal UNII lookup

Harmonized RxCUI identifiers#

RxCUI identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
Identifier	FDA.report destination
308416	Internal RxNorm lookup

Harmonized SPL set identifiers#

SPL set identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
Identifier	FDA.report destination
4522f745-b88d-4021-a5dc-0161f1967dc9	Available on FDA.report

DailyMed Product Concepts#

Product concept, Relation, Version table
Product concept	Relation	Version	Effective
594e2c86-3079-4e6e-96c9-48f7a8afc78d	Product name	1	20230718
d7724692-1155-4cc8-a415-22f5fc4aec35	Product name	6	20220216
bde672ba-4805-28d0-1986-73543d41b412	Product name	2	20210201
f212291f-05fe-9603-fc7e-bd73e38ce1e6	Product name	2	20161129
ade821ba-260a-47e2-bd89-743e27ac9906	Product name	1	20161121
182f9ab4-4ab5-c449-200f-87ce2ce8e550	Product name	2	20151105
9425d234-4ae1-4b53-adc6-8cc7af6dd657	Product name	1	20150929
2a21311a-89e2-0e83-2ebd-117f9798b2b2	Product name	1	20140508
9007e8a7-ff50-f9b9-7945-f2a1deadd94e	Product name	1	20140508
96c2be53-8e44-452d-56a2-d255b2f1af2d	Product name	1	20140508
bf8bd5f7-495f-4022-2780-7ded7ea7ea44	Product name	1	20140508

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Related label table
NDC	Effective	Related label
16103-356-09	2025-01-30	Drug Facts
16103-356-11	2025-01-30	Drug Facts
16103-356-09	2023-06-08	Drug Facts
16103-356-11	2023-06-08	Drug Facts
16103-356-09	2023-01-30	Drug Facts
16103-356-11	2023-01-30	Drug Facts
16103-356-09	2021-03-29	Drug Facts
16103-356-11	2021-03-29	Drug Facts
16103-356-09	2020-01-31	Drug Facts
16103-356-11	2020-01-31	Drug Facts

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDC	Product	Description	Form	Quantity	SPL version
16103-356-09	Adult Low Dose Aspirin	1 in 1 CARTON	TABLET, DELAYED RELEASE	1	4
16103-356-09	Adult Low Dose Aspirin	120 in 1 BOTTLE, PLASTIC	TABLET, DELAYED RELEASE	120	4
16103-356-11	Adult Low Dose Aspirin	1000 in 1 BOTTLE, PLASTIC	TABLET, DELAYED RELEASE	1000	4

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDC	Billing unit	Product NDC	DailyMed indexing SPL	SPL version	Effective
16103-356-09	EA - Each	16103-356	2a4fc101-b4b3-4006-94da-4dcc4f99468a	1	2012-07-24
16103-356-11	EA - Each	16103-356	5401e9c5-7206-4514-b71f-0844577ed8af	1	2012-07-24

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
Ingredient	Type	UNII	DailyMed label	SPL version
ASPIRIN	ACTIVE INGREDIENT	R16CO5Y76E	ADULT LOW DOSE ASPIRIN (ASPIRIN) TABLET, DELAYED RELEASE [PHARBEST PHARMACEUTICALS, INC.]	1
ASPIRIN	ACTIVE INGREDIENT	R16CO5Y76E	ADULT LOW DOSE ASPIRIN (ASPIRIN) TABLET, DELAYED RELEASE [LIBERTY PHARMACEUTICALS, INC.]	1
ASPIRIN	ACTIVE INGREDIENT	R16CO5Y76E	ADULT LOW DOSE ASPIRIN (ASPIRIN) TABLET, DELAYED RELEASE [AIDAREX PHARMACEUTICALS LLC]	1
ASPIRIN	ACTIVE INGREDIENT	R16CO5Y76E	ASPIRIN LOW DOSE (ASPIRIN) TABLET, FILM COATED [CONTRACT PHARMACY SERVICES-PA]	1
ASPIRIN	ACTIVE MOIETY	R16CO5Y76E	ADULT LOW DOSE ASPIRIN (ASPIRIN) TABLET, DELAYED RELEASE [LIBERTY PHARMACEUTICALS, INC.]	1
ASPIRIN	ACTIVE MOIETY	R16CO5Y76E	ADULT LOW DOSE ASPIRIN (ASPIRIN) TABLET, DELAYED RELEASE [AIDAREX PHARMACEUTICALS LLC]	1
ASPIRIN	ACTIVE MOIETY	R16CO5Y76E	ADULT LOW DOSE ASPIRIN (ASPIRIN) TABLET, DELAYED RELEASE [PHARBEST PHARMACEUTICALS, INC.]	1
ASPIRIN	ACTIVE MOIETY	R16CO5Y76E	ASPIRIN LOW DOSE (ASPIRIN) TABLET, FILM COATED [CONTRACT PHARMACY SERVICES-PA]	1
CELLULOSE, MICROCRYSTALLINE	INACTIVE INGREDIENT	OP1R32D61U	ADULT LOW DOSE ASPIRIN (ASPIRIN) TABLET, DELAYED RELEASE [PHARBEST PHARMACEUTICALS, INC.]	1
CELLULOSE, MICROCRYSTALLINE	INACTIVE INGREDIENT	OP1R32D61U	ADULT LOW DOSE ASPIRIN (ASPIRIN) TABLET, DELAYED RELEASE [LIBERTY PHARMACEUTICALS, INC.]	1
CELLULOSE, MICROCRYSTALLINE	INACTIVE INGREDIENT	OP1R32D61U	ADULT LOW DOSE ASPIRIN (ASPIRIN) TABLET, DELAYED RELEASE [AIDAREX PHARMACEUTICALS LLC]	1
CROSCARMELLOSE SODIUM	INACTIVE INGREDIENT	M28OL1HH48	ADULT LOW DOSE ASPIRIN (ASPIRIN) TABLET, DELAYED RELEASE [LIBERTY PHARMACEUTICALS, INC.]	1
CROSCARMELLOSE SODIUM	INACTIVE INGREDIENT	M28OL1HH48	ADULT LOW DOSE ASPIRIN (ASPIRIN) TABLET, DELAYED RELEASE [PHARBEST PHARMACEUTICALS, INC.]	1
CROSCARMELLOSE SODIUM	INACTIVE INGREDIENT	M28OL1HH48	ADULT LOW DOSE ASPIRIN (ASPIRIN) TABLET, DELAYED RELEASE [AIDAREX PHARMACEUTICALS LLC]	1
D&C YELLOW NO. 10	INACTIVE INGREDIENT	35SW5USQ3G	ADULT LOW DOSE ASPIRIN (ASPIRIN) TABLET, DELAYED RELEASE [AIDAREX PHARMACEUTICALS LLC]	1
D&C YELLOW NO. 10	INACTIVE INGREDIENT	35SW5USQ3G	ADULT LOW DOSE ASPIRIN (ASPIRIN) TABLET, DELAYED RELEASE [LIBERTY PHARMACEUTICALS, INC.]	1
D&C YELLOW NO. 10	INACTIVE INGREDIENT	35SW5USQ3G	ADULT LOW DOSE ASPIRIN (ASPIRIN) TABLET, DELAYED RELEASE [PHARBEST PHARMACEUTICALS, INC.]	1
FD&C YELLOW NO. 6	INACTIVE INGREDIENT	H77VEI93A8	ADULT LOW DOSE ASPIRIN (ASPIRIN) TABLET, DELAYED RELEASE [AIDAREX PHARMACEUTICALS LLC]	1
FD&C YELLOW NO. 6	INACTIVE INGREDIENT	H77VEI93A8	ADULT LOW DOSE ASPIRIN (ASPIRIN) TABLET, DELAYED RELEASE [PHARBEST PHARMACEUTICALS, INC.]	1
FD&C YELLOW NO. 6	INACTIVE INGREDIENT	H77VEI93A8	ADULT LOW DOSE ASPIRIN (ASPIRIN) TABLET, DELAYED RELEASE [LIBERTY PHARMACEUTICALS, INC.]	1
HYPROMELLOSES	INACTIVE INGREDIENT	3NXW29V3WO	ADULT LOW DOSE ASPIRIN (ASPIRIN) TABLET, DELAYED RELEASE [LIBERTY PHARMACEUTICALS, INC.]	1
HYPROMELLOSES	INACTIVE INGREDIENT	3NXW29V3WO	ADULT LOW DOSE ASPIRIN (ASPIRIN) TABLET, DELAYED RELEASE [PHARBEST PHARMACEUTICALS, INC.]	1
HYPROMELLOSES	INACTIVE INGREDIENT	3NXW29V3WO	ADULT LOW DOSE ASPIRIN (ASPIRIN) TABLET, DELAYED RELEASE [AIDAREX PHARMACEUTICALS LLC]	1
METHACRYLIC ACID - ETHYL ACRYLATE COPOLYMER (1:1) TYPE A	INACTIVE INGREDIENT	NX76LV5T8J	ADULT LOW DOSE ASPIRIN (ASPIRIN) TABLET, DELAYED RELEASE [AIDAREX PHARMACEUTICALS LLC]	1
METHACRYLIC ACID - ETHYL ACRYLATE COPOLYMER (1:1) TYPE A	INACTIVE INGREDIENT	NX76LV5T8J	ADULT LOW DOSE ASPIRIN (ASPIRIN) TABLET, DELAYED RELEASE [LIBERTY PHARMACEUTICALS, INC.]	1
METHACRYLIC ACID - ETHYL ACRYLATE COPOLYMER (1:1) TYPE A	INACTIVE INGREDIENT	NX76LV5T8J	ADULT LOW DOSE ASPIRIN (ASPIRIN) TABLET, DELAYED RELEASE [PHARBEST PHARMACEUTICALS, INC.]	1
POLYETHYLENE GLYCOLS	INACTIVE INGREDIENT	3WJQ0SDW1A	ADULT LOW DOSE ASPIRIN (ASPIRIN) TABLET, DELAYED RELEASE [LIBERTY PHARMACEUTICALS, INC.]	1
POLYETHYLENE GLYCOLS	INACTIVE INGREDIENT	3WJQ0SDW1A	ADULT LOW DOSE ASPIRIN (ASPIRIN) TABLET, DELAYED RELEASE [AIDAREX PHARMACEUTICALS LLC]	1
POLYETHYLENE GLYCOLS	INACTIVE INGREDIENT	3WJQ0SDW1A	ADULT LOW DOSE ASPIRIN (ASPIRIN) TABLET, DELAYED RELEASE [PHARBEST PHARMACEUTICALS, INC.]	1
SODIUM LAURYL SULFATE	INACTIVE INGREDIENT	368GB5141J	ADULT LOW DOSE ASPIRIN (ASPIRIN) TABLET, DELAYED RELEASE [AIDAREX PHARMACEUTICALS LLC]	1
SODIUM LAURYL SULFATE	INACTIVE INGREDIENT	368GB5141J	ADULT LOW DOSE ASPIRIN (ASPIRIN) TABLET, DELAYED RELEASE [PHARBEST PHARMACEUTICALS, INC.]	1
SODIUM LAURYL SULFATE	INACTIVE INGREDIENT	368GB5141J	ADULT LOW DOSE ASPIRIN (ASPIRIN) TABLET, DELAYED RELEASE [LIBERTY PHARMACEUTICALS, INC.]	1
STARCH, CORN	INACTIVE INGREDIENT	O8232NY3SJ	ADULT LOW DOSE ASPIRIN (ASPIRIN) TABLET, DELAYED RELEASE [AIDAREX PHARMACEUTICALS LLC]	1
STARCH, CORN	INACTIVE INGREDIENT	O8232NY3SJ	ADULT LOW DOSE ASPIRIN (ASPIRIN) TABLET, DELAYED RELEASE [PHARBEST PHARMACEUTICALS, INC.]	1
STARCH, CORN	INACTIVE INGREDIENT	O8232NY3SJ	ADULT LOW DOSE ASPIRIN (ASPIRIN) TABLET, DELAYED RELEASE [LIBERTY PHARMACEUTICALS, INC.]	1
STEARIC ACID	INACTIVE INGREDIENT	4ELV7Z65AP	ADULT LOW DOSE ASPIRIN (ASPIRIN) TABLET, DELAYED RELEASE [PHARBEST PHARMACEUTICALS, INC.]	1
STEARIC ACID	INACTIVE INGREDIENT	4ELV7Z65AP	ADULT LOW DOSE ASPIRIN (ASPIRIN) TABLET, DELAYED RELEASE [LIBERTY PHARMACEUTICALS, INC.]	1
STEARIC ACID	INACTIVE INGREDIENT	4ELV7Z65AP	ADULT LOW DOSE ASPIRIN (ASPIRIN) TABLET, DELAYED RELEASE [AIDAREX PHARMACEUTICALS LLC]	1
TALC	INACTIVE INGREDIENT	7SEV7J4R1U	ADULT LOW DOSE ASPIRIN (ASPIRIN) TABLET, DELAYED RELEASE [PHARBEST PHARMACEUTICALS, INC.]	1
TALC	INACTIVE INGREDIENT	7SEV7J4R1U	ADULT LOW DOSE ASPIRIN (ASPIRIN) TABLET, DELAYED RELEASE [LIBERTY PHARMACEUTICALS, INC.]	1
TALC	INACTIVE INGREDIENT	7SEV7J4R1U	ADULT LOW DOSE ASPIRIN (ASPIRIN) TABLET, DELAYED RELEASE [AIDAREX PHARMACEUTICALS LLC]	1
TITANIUM DIOXIDE	INACTIVE INGREDIENT	15FIX9V2JP	ADULT LOW DOSE ASPIRIN (ASPIRIN) TABLET, DELAYED RELEASE [AIDAREX PHARMACEUTICALS LLC]	1
TITANIUM DIOXIDE	INACTIVE INGREDIENT	15FIX9V2JP	ADULT LOW DOSE ASPIRIN (ASPIRIN) TABLET, DELAYED RELEASE [PHARBEST PHARMACEUTICALS, INC.]	1
TITANIUM DIOXIDE	INACTIVE INGREDIENT	15FIX9V2JP	ADULT LOW DOSE ASPIRIN (ASPIRIN) TABLET, DELAYED RELEASE [LIBERTY PHARMACEUTICALS, INC.]	1

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDC	Dashboard title	SPL version	Validation	Dashboard ZIP
16103-356	ADULT LOW DOSE ASPIRIN (ASPIRIN) TABLET, DELAYED RELEASE [PHARBEST PHARMACEUTICALS, INC.]	3	Current NDC, Legacy NDC, 3 package rows	20230609_4522f745-b88d-4021-a5dc-0161f1967dc9.zip

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 6 · 111 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
MG DermaSpray 70	ETHYL ALCOHOL	Morgan Gallacher Inc. DBA Custom Chemical Formulators Inc.	153ed8ff-5632-4f21-84de-2b87ac2bef31	2026-08-04	Warnings	Exact identifier application number: M
The Original Mane n Tail Daily Control 2 in 1 Anti Dandruff	PYRITHIONE ZINC	Straight Arrow Products Inc	68ab55d6-b1a9-46c0-87f0-ec12ad3474bc	2026-07-09	Warnings	Exact identifier application number: M
Stool Softener Laxative	DOCUSATE SODIUM	ATLANTIC BIOLOGICALS CORP.	c1f588d0-4600-4b97-b2d3-2c08ac351e07	2026-06-30	Warnings	Exact identifier application number: M
Docusate Sodium	DOCUSATE SODIUM	PD-Rx Pharmaceuticals, Inc.	66ca7a94-378b-4476-8060-d9c6f82f57fc	2026-06-12	Warnings	Exact identifier application number: M
TRIBIOTIC	BACITRACIN ZINC, NEOMYCIN SULFATE, POLYMYXIN B SULFATE	HART Health	3d17aba0-220f-42c4-9e26-5c44857847cd	2026-05-20	Warnings, Adverse reactions	Exact identifier application number: M
IT Cosmetics Your Skin But Better CC Plus Color Correcting Broad Spectrum SPF 50 Plus Sunscreen Full Coverage Deep Deep Honey Deep Bronze Neutral Deep Deep Mocha Tan Cool Rich Cool Deep Cool Neutral Rich	HOMOSALATE, OCTISALATE AND OCTOCRYLENE	LOreal USA Products Inc	2a44a019-0cc0-439b-aaa5-37582ec5492e	2026-05-14	Warnings	Exact identifier application number: M
THORACOL	HONEY LEMON COUGH DROPS	HART Health	fee9f594-c619-4d77-bb52-632078e0254e	2026-04-16	Warnings	Exact identifier application number: M
First Aid and Burn	BENZALKONIUM CHLORIDE, LIDOCAINE	HART Health	07d447f1-469c-4e34-b807-ede9a449e6ab	2026-04-15	Warnings	Exact identifier application number: M
HYDROCORTISONE	HYDROCORTISONE CREAM	HART Health	c76fb030-cbb5-4773-aa52-d038cb41d0af	2026-04-15	Warnings	Exact identifier application number: M
Hydrogen Peroxide	HYDROGEN PEROXIDE	Amazon.com Services LLC	55b0d905-fcc0-40ba-a5dd-331a27a3a209	2026-04-07	Warnings, Adverse reactions	Exact identifier application number: M
Docusate Sodium	DOCUSATE SODIUM 100MG	Pharbest Pharmaceuticals, Inc.	025e03e0-e273-47ed-87f7-98e388abe047	2026-03-05	Warnings	Exact identifier application number: M
TEENY TUMMY Gas Relief Drops	SIMETHICONE	ALTANTIC BIOLOGICAS CORP.	05eadb73-4468-4dae-a67b-133d893feed2	2026-02-13	Warnings	Exact identifier application number: M
Relief-PE	ACETAMINOPHEN, PHENYLEPHRINE, CHLORPHENIRAMINE	HART Health	9475fb51-931b-4a89-be6b-62e715d0883e	2026-01-15	Warnings	Exact identifier application number: M
ASPIRIN	ASPIRIN	HART Health	a1c73edf-861d-478b-9d3c-0eddcc6879cc	2026-01-14	Warnings	Exact identifier application number: M
HISTAPRIN	DIPHENHYDRAMINE	NorMed	38786a65-a12b-4479-b63c-b7c15410da04	2026-01-14	Warnings	Exact identifier application number: M
Blood Clotting	BENZETHONIUM CHLORIDE AND LIDOCAINE	HART Health	21668731-8b8a-404f-80ab-962a0a9d5f63	2026-01-14	Warnings	Exact identifier application number: M
Bandage	BENZOCAINE AND BENZETHONIUM CHLORIDE	HART Health	6de57472-6dd0-43b6-8a82-fe459fa99ddb	2026-01-14	Warnings	Exact identifier application number: M
Sooth-a-Sting	BENZOCAINE, ISOPROPYL ALCOHOL	HART Health	c0e7d661-a9c9-4656-a516-57552848ebe8	2026-01-12	Warnings	Exact identifier application number: M
Alcohol	ISOPROPYL ALCOHOL	HART Health	8d01b10b-7916-420e-9d44-ebd3806fe315	2026-01-12	Warnings	Exact identifier application number: M
Eye Clean	EYE WASH	HART Health	41f53e2e-c2bc-4bf1-a541-3bcb2cf63002	2025-12-31	Warnings	Exact identifier application number: M

UNII, Preferred term, Registry number table
UNII	Preferred term	Registry number	Matched term
R16CO5Y76E	ASPIRIN	50-78-2	ASPIRIN

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUI	RxNorm string	TTY	DailyMed	SPL version
308416	aspirin 81 MG Delayed Release Oral Tablet	PSN	ef9d5cea-86f1-44c2-bca4-70ff5fa16356	11
308416	aspirin 81 MG Delayed Release Oral Tablet	SCD	ef9d5cea-86f1-44c2-bca4-70ff5fa16356	11
308416	ASA 81 MG Delayed Release Oral Tablet	SY	ef9d5cea-86f1-44c2-bca4-70ff5fa16356	11
308416	aspirin 81 MG Enteric Coated Oral Tablet	SY	ef9d5cea-86f1-44c2-bca4-70ff5fa16356	11
308416	aspirin 81 MG Delayed Release Oral Tablet	PSN	4522f745-b88d-4021-a5dc-0161f1967dc9	4
308416	aspirin 81 MG Delayed Release Oral Tablet	SCD	4522f745-b88d-4021-a5dc-0161f1967dc9	4
308416	ASA 81 MG Delayed Release Oral Tablet	SY	4522f745-b88d-4021-a5dc-0161f1967dc9	4
308416	aspirin 81 MG Enteric Coated Oral Tablet	SY	4522f745-b88d-4021-a5dc-0161f1967dc9	4
308416	aspirin 81 MG Delayed Release Oral Tablet	PSN	1b2e6566-cb7c-7a7d-e063-6394a90af97c	2
308416	aspirin 81 MG Delayed Release Oral Tablet	SCD	1b2e6566-cb7c-7a7d-e063-6394a90af97c	2
308416	ASA 81 MG Delayed Release Oral Tablet	SY	1b2e6566-cb7c-7a7d-e063-6394a90af97c	2
308416	aspirin 81 MG Enteric Coated Oral Tablet	SY	1b2e6566-cb7c-7a7d-e063-6394a90af97c	2
308416	aspirin 81 MG Delayed Release Oral Tablet	PSN	466f6fa5-79f9-4f53-971d-a5254b0750e3	1
308416	aspirin 81 MG Delayed Release Oral Tablet	PSN	47b595dd-51ff-4400-91d5-c814a5c80eb4	1
308416	aspirin 81 MG Delayed Release Oral Tablet	PSN	b427f43b-6c79-4141-9709-8da63d198cc8	1
308416	aspirin 81 MG Delayed Release Oral Tablet	SCD	466f6fa5-79f9-4f53-971d-a5254b0750e3	1
308416	aspirin 81 MG Delayed Release Oral Tablet	SCD	47b595dd-51ff-4400-91d5-c814a5c80eb4	1
308416	aspirin 81 MG Delayed Release Oral Tablet	SCD	b427f43b-6c79-4141-9709-8da63d198cc8	1
308416	ASA 81 MG Delayed Release Oral Tablet	SY	47b595dd-51ff-4400-91d5-c814a5c80eb4	1
308416	ASA 81 MG Delayed Release Oral Tablet	SY	b427f43b-6c79-4141-9709-8da63d198cc8	1
308416	ASA 81 MG Delayed Release Oral Tablet	SY	466f6fa5-79f9-4f53-971d-a5254b0750e3	1
308416	aspirin 81 MG Enteric Coated Oral Tablet	SY	466f6fa5-79f9-4f53-971d-a5254b0750e3	1
308416	aspirin 81 MG Enteric Coated Oral Tablet	SY	47b595dd-51ff-4400-91d5-c814a5c80eb4	1
308416	aspirin 81 MG Enteric Coated Oral Tablet	SY	b427f43b-6c79-4141-9709-8da63d198cc8	1

Packages#

Package NDC, 11-digit format, Description table
Package NDC	11-digit format	Description	Marketing start	Marketing end	Sample	Exclude flag	Status
16103-356-09	16103035609	1 BOTTLE, PLASTIC in 1 CARTON (16103-356-09) / 120 TABLET, DELAYED RELEASE in 1 BOTTLE, PLASTIC	2007-01-12	0000-00-00	No	No	Current
16103-356-11	16103035611	1000 TABLET, DELAYED RELEASE in 1 BOTTLE, PLASTIC (16103-356-11)	2007-01-12	0000-00-00	No	No	Current

Title, Manufacturer, Effective date table
Title	Manufacturer	Effective date	Type	Version
Drug Facts	Pharbest Pharmaceuticals, Inc.	2025-12-24	HUMAN OTC DRUG LABEL	4
Drug Facts	PD-Rx Pharmaceuticals, Inc.	2024-10-15	HUMAN OTC DRUG LABEL	10
Drug Facts	PD-Rx Pharmaceuticals, Inc.	2024-10-08	HUMAN OTC DRUG LABEL	9
Aspirin 81mg Adult Low Dose - PHARMAMED USA INC \| PHARBEST PHARMACEUTICALS, INC.	PHARMAMED USA INC \| PHARBEST PHARMACEUTICALS, INC.	2024-06-26	HUMAN OTC DRUG LABEL	2
ADULT LOW DOSE ASPIRIN	DIRECT RX	2023-06-28	HUMAN OTC DRUG LABEL	5
Drug Facts	Denton Pharma, Inc. DBA Northwind Pharmaceuticals	2021-07-27	HUMAN OTC DRUG LABEL	2
Drug Facts	A-S Medication Solutions	2021-04-14	HUMAN OTC DRUG LABEL	11
Drug Facts	Liberty Pharmaceuticals, Inc.	2013-09-20	HUMAN OTC DRUG LABEL	1
Drug Facts	Aidarex Pharmaceuticals LLC	2012-09-11	HUMAN OTC DRUG LABEL	1
Aspirin Low Tablets	Contract Pharmacy Services-PA	2010-07-30	HUMAN OTC DRUG LABEL	1